Related by context. All words. (Click for frequent words.) 52 Determinations 51 Hardwork 51 determination 50 Estoppel 49 Adverse Effect 48 Nondiscrimination 48 Persistence 48 Main Outcome Measures 47 Assesment 47 Reevaluation 47 Stipulated 47 Arbitration Agreements 47 Lacked 47 Confirmatory 47 CHMP Opinion 46 Clarified 46 Overstepping 46 Rearrangement 46 Committment 46 Proposed Rule Changes 46 Steadiness 46 Order Authorizing 46 Determines 46 Main Outcome Measure 45 Obviousness 45 Equalisation 45 Acknowledgement 45 Liquidated Damages 45 Hormonal Therapy 45 Remains Unclear 45 Toughness 45 Unyielding 45 Selection Criteria 45 Dedication 45 Parentage 45 Success Depends 45 Filing Requirements 45 Attainment 45 Listing Compliance 45 Acceptability 44 Differentiated 44 Residency Requirement 44 Recalculation 44 Significant Improvements 44 Issues Relating 44 #.#-# [020] 44 Assessing 44 Enforceability 44 Complementarity 44 Ensured 44 Evaluation Process 44 Substantial Completion 44 Inequitable Conduct 44 Conditional Approval 44 Delineation 44 Disciplinary Procedures 44 Approvable 44 Distinctiveness 44 Detrimental 44 Unambiguous 44 Occupational Exposure 44 Causation 44 NASDAQ Delisting 44 Diminishes 43 Minimization 43 Numbering System 43 WAC #-#-# 43 Injunctive Relief 43 Order Granting 43 Determine 43 Results Confirm 43 Regarding Minimum Bid 43 Reconstitute 43 Prognostic 43 Comprehensiveness 43 Improving Efficiency 43 Underlines 43 Voluntary Dismissal 43 Maintenance Requirements 43 Unfairness 43 Variable Interest Entities FIN 43 Declarations 43 Waste Discharge 43 Appealed 43 Effort Fails 43 Orally Active 43 Resourcefulness 43 Underlies 43 Dictates 43 Attained 43 Requirement 43 Decision 43 Lofty Goals 43 Miscellaneous Amendments 43 Adaptability 43 Nasdaq Minimum Bid 43 Sufficiency 43 Resubmission 43 Predict Prostate Cancer 43 Constancy 43 Urgency 43 Specificity 42 Evoked 42 Determining 42 Uniqueness 42 Variable Compensation 42 Protein Synthesis 42 Transferable Skills 42 Recusal 42 Aggressiveness 42 Helps Identify 42 Permit Application 42 Justification 42 Athleticism 42 Limitation 42 Antidumping Duties 42 Therapeutic Intervention 42 Remains Uncertain 42 Responsiveness 42 Disease Severity 42 Impairs 42 Deficiency 42 Medicure Announces 42 Greystar Resources Announces 42 License Revocation 42 Early Termination 42 Proposed Changes 42 Discipline 42 Data Exclusivity 42 Self Efficacy 42 Trait 42 Data Suggest 42 Operability 42 Hematological Cancers 42 Potency 42 Poses Challenges 42 Revocation 42 Selflessness 42 Reaffirmation 42 Collaborative Approach 42 License Application 42 Signifies 42 Appraised Value 42 Left Ventricular 42 Dependability 42 Panel Advises 42 Ineligibility 42 Impartiality 42 Suitability 42 Unmet Medical 42 Mandatory Arbitration 42 Skin Irritation 42 Prolongs 42 PDL BioPharma Announces 42 Quantification 42 Notice 42 Technical Specifications 42 Treating Chronic 42 Inappropriate Conduct 42 Determinant 42 Recognition 42 Left Atrial 42 Predisposition 42 NASDAQ Minimum Bid 41 Stockholder Approval 41 Harsh Interrogation 41 Positive Outcome 41 Signaling Pathways 41 Announce Filing 41 Trade Liberalization 41 Breast Cancer Recurrence 41 Strongly Linked 41 Infraction 41 Epithelial Cell 41 § #A.# 41 Retest 41 Strength 41 Proposed Rule Change 41 Radiation Induced 41 DFAR #.#-# 41 Proposes Tougher 41 Remains Unchanged 41 Mitigated 41 Worse Than Thought 41 Can Predict 41 Predictive Value 41 Comment Period 41 Inhibit 41 Selection Procedures 41 Adjustment 41 Arbitrate 41 Quickly Approaching 41 Presumption 41 Novel Inhibitor 41 Structural Changes 41 Prioritized 41 Evidentiary 41 Arbitration Clauses 41 Confusion Reigns Over 41 Contingent Commissions 41 Quantifiable 41 Alleged Violation 41 Variability 41 Patent Term 41 Court Voids 41 Anti Tumor Activity 41 Differentially 41 Voided 41 Reiterate 41 Neutralizing Antibodies 41 Teamwork 41 Tumor Cells 41 Psychological Effects 41 Hotly Debated 41 Reasonable Accommodation 41 Prequalification 41 Attorneys Fees 41 Sour Economy 41 Accounting Practices 41 Pinnacle Digest Opinions Requested 41 Faces Stiff 41 Estimation 41 Positive Attitude 41 Transparency Accountability 41 Total Hip Arthroplasty 41 Transfer Agreement 41 Restrains 41 Homogeneity 41 Cell Adhesion 41 Perseverance 41 Misconceptions About 41 Delist Common Stock 41 No. #R Consolidation 41 Depressive Symptoms 41 Stricter Rules 41 Cardiac Marker 41 Deference 41 Probable Cause 41 Removing Barriers 41 entitled Compositions 41 Justifiable 41 Unenforceable 41 Interlocutory 41 Disciplinary Action 41 Seriously Flawed 41 Imperfection 41 Continued Listing Requirements 41 Formulates 41 Gene Variants 41 Expert Discusses 41 Postpones Decision 41 Satellite Radio Merger 41 Accelerated Approval 41 Promulgation 41 Inhaled Nitric Oxide 41 Acclimation 41 Designation 41 Termination Notice 41 Emphasises 41 Disallowed 41 License Suspension 41 Non Negotiable 41 Reexamination 41 Permissive 41 Comprehension 41 Serious Flaws 40 Determinants 40 Waiver Request 40 XM Sirius Merger 40 Ethical Considerations 40 Homeostasis 40 FOIA Requests 40 Procedure 40 Referential 40 Classify 40 Ethnic Differences 40 Devalued 40 Could Complicate 40 NYSE Amex Listing 40 Transitional Provisions 40 Structural Damage 40 Diet Supplement 40 First BanCorp Announces 40 Qualities 40 Negative Effects 40 Corrective Actions 40 Consequential 40 Nullified 40 Equanimity 40 Genuine Occupational 40 Attribute 40 Exemption 40 Patent Reexamination 40 Apoptotic 40 Voluntary Guidelines 40 Could Weaken 40 Discriminates 40 Pecuniary 40 .W. McNichols 40 Trademark Dispute 40 Gender Differences 40 B.1 40 Garnishment 40 Mineral Extraction 40 Annuls 40 Equivalence 40 Recoupment 40 Determination Letter 40 Accelerated Expiry Date 40 Researchers Uncover 40 Concession Arrangements 40 Defendant Motion 40 Respect 40 Interprets 40 Respect Responsibility 40 Import Restrictions 40 Diminish 40 Resale Registration Statement 40 Validation 40 Benefits Outweigh 40 Socioeconomic Status 40 Regained 40 Border Demarcation 40 Deferment 40 Lexical 40 Ineffective Assistance 40 Adjudicatory 40 Terminates Letter 40 SABESP Announces 40 Stockholder Vote 40 Exercise Induced Asthma 40 Worthiness 40 NASDAQ Listing 40 Could Hinder 40 De Minimis 40 Empower Yourself 40 Be Short Lived 40 Intractable Hiccups 40 Resolution Approving 40 Molecular Structure 40 easyhome Ltd. Announces 40 Use Thereof 40 Test Detects 40 Signaled 40 Functional Outcomes 40 Upholds Ruling 40 Minimum Bid 40 Osteoarthritis Patients 40 Germline 40 CSR #-#.# 40 Marked Improvement 40 Redetermination 40 Viral Suppression 40 Becomes Effective 40 Smooth Transition 40 3rd edn 40 Non Exempt 40 Stipulated Order 40 Disease Causing 40 Teacher Evaluations 40 Combo Therapy 40 Differs 40 Reasonable Suspicion 40 Procedural Rules 40 Readjustment 40 Chronic Illness Therapy 40 Amended Notice 40 C.# 40 Gene Mutation 40 Calculates 40 Respond Quickly 40 Correlates 40 Reassess 40 NUREG 40 Timeliness 40 Considers Changing 40 Restraint 40 Proliferative 40 NOTE WORTHY 40 END FOOTNOTE 40 Be Eased 40 Practicable 40 Requester 40 Demonstrates Statistically Significant 40 #.# 5T 40 Motivation 40 Compliance Statement 40 Prognostic Factors 40 Mechanic Lien 40 Formal Complaint 40 Compensatory 40 Suppresses 40 Discharge Permit 40 Repeatability 40 Hastened 40 Human Error 40 Efficacy Endpoints 40 Deductibility 40 Commerciality 40 Highly Sensitive 40 Revalidation 40 Proposes Changes 40 Files Provisional 40 Anti Tumor 40 Remedial Review 40 Must Carry 40 Mind Boggling 40 Declaratory 40 Study Sheds Light 40 Patentability 40 Draws Mixed 40 Panel Mulls 40 Screening Mammography 40 Selectivity 40 Favorable Decision 40 Difficult Task 40 Designations 40 Flexibility 40 Practical Guidance 40 XXX Domain 40 Recommends Changes 40 Judgements 40 Servitude 40 Enforceable 40 Impair 40 Hepatitis C Treatment 40 Finality 40 Simplified Acquisition 40 Gastar Exploration Announces 40 Exh 40 Alleged Violations 40 Dramatically Reduce 40 Face Tougher 40 Significant Impact 39 Certain Cancers 39 Proportionality 39 Listing Deficiency 39 Critically Ill Patients 39 Precautionary Measures 39 Digit Symbol Substitution 39 Unwavering 39 Criteria 39 Federally Mandated 39 Revised 39 Emotional Distress 39 Sustained Growth 39 Overestimated 39 Lupus Drug 39 Remain Listed 39 #.#.#.#.# [004] 39 Recommended Practices 39 Assessed 39 Consistency 39 Molecular Mechanism 39 Antidepressant Treatment 39 Solicitation Number 39 Substantial Increase 39 Stmt 39 Character Trait 39 Study Analyzes 39 Timely Manner 39 Could Predict 39 Enhance Shareholder 39 Recommendation 39 Rezoning Request 39 Intra Arterial 39 Highest Ever 39 Renal Function 39 Reasonableness 39 Significance 39 Long Term Survival 39 Ozone Pollution 39 Operational Capabilities 39 Sleep Disturbance 39 Cost Adjustment 39 Greatly Improve 39 Rejects Request 39 Innate 39 Conformational 39 Stable Angina 39 Second Supplementary Bidder 39 #.#-# [001] 39 Withdraws Request 39 Negotiated Settlement 39 Be Abolished 39 Lacks 39 Challenges Posed 39 Joint Stipulation 39 Clinically Significant 39 #.#-# [033] 39 #.#-# Affirmative Action 39 Reexamine 39 Technicalities 39 Could Undermine 39 Casts Doubts 39 Shows Promise Against 39 Versatility 39 Trustworthiness 39 Relevance 39 Annuity Transactions Model 39 Anabolic Steroid 39 Inadequacy 39 Genetic Mutation 39 Scientists Identify 39 Excess Capacity 39 Discrepancy 39 Nullity 39 Rescinded 39 Could Hamper 39 Consequential Amendments 39 Correlation Between 39 Lung Cancer Treatment 39 Declaratory Relief 39 Pub. 39 Intents 39 Dividend Distribution 39 Imbalance 39 Allowable 39 Sees Gradual 39 Filing Deadlines 39 Court Overrules 39 Prognostic Value 39 #A.# [003] 39 Mandatory Retirement 39 Faithfulness 39 Vitamin D Supplementation 39 Rehearing 39 Irrevocable 39 Deadline Approaches 39 Trade Offs 39 Majority Voting 39 Fatally Flawed 39 FASB Interpretation 39 Reconsideration 39 Interchange Format 39 Hr'g Tr 39 Prescriptive 39 Ambient Noise 39 No Stinkin 39 Hardship 39 Lymph Nodes 39 Nasdaq Notice Regarding 39 Symbol Change 39 Fact Conclusions 39 Limitations 39 Exercise Exercise 39 Appears Safe 39 Undisputed Facts 39 Remains Unknown 39 Hematopoietic Stem Cells 39 Study Underscores 39 Differs From 39 Confusion Surrounds 39 Admissible 39 Reduction 39 hereby GRANTED 39 Success Hinges 39 Extraterritorial 39 Flexsteel Announces 39 MYPD 39 Study Reinforces 39 Invalidity 39 Recapture 39 Endocrine Disruptors 39 More Harm Than 39 Honesty 39 Nagorno Karabakh Conflict 39 Fulfil 39 Certifi cate 39 Rapidly Approaching 39 Dkt 39 Maturation 39 Action Lawsuit 39 Potentially Hazardous 39 Modulating 39 Likely Delayed 39 Thyroid Function 39 Conjugates 39 Mitigating Climate Change 39 Legal #.# 39 Begin Clinical Trials 39 Ephedra Ban 39 ALABAMA VOICES 39 Emphasizes 39 Shareholder Proposals 39 Subdivision Regulations 39 Acceptance 39 Clinical Outcome 39 exp MORE 39 Enumeration 39 FBLA Principles 39 Study Shows Benefits 39 Logistic Regression 39 Re Examine 39 Reappraisal 39 Rigidity 39 Hindrance 39 GASB Issues 39 Pricing Supplement 39 Section #A.# 39 Stress Hormone 39 Criticality 39 First Trimester 39 Differential Diagnosis 39 Highly Selective 39 Study Assesses 39 Panel Upholds 39 Lorus Therapeutics Announces 39 Antitumor 39 Unfailing 39 Statement FEIS 39 Clears Path 39 Commercial Viability 39 Listing Requirement 39 Interpretation 39 Must Prove 39 Resp't 39 Biogeochemical 39 Provides Clues 39 Reply Brief 39 Reactor Shutdown 39 Liver Function 39 Tumor Suppressor Gene 39 Statement 39 Deliverable 39 Iron Deficiency 39 Credit Card Consolidation 39 Reaffirm 39 Complete Qualifying Transaction 39 Face Daunting 39 Redefinition 39 Applicability 39 OSLER 39 Immeasurable 39 Protein Involved 39 Deferral 39 CONSOL Energy Declares Regular 39 Imposed 39 Commission Decision #/#/EC 39 Still Unclear 39 Mental Status 39 Gene Variation 39 Dominance 39 Preferable 39 Conformance 39 Folic Acid Fortification 39 :3 39 Path Toward 39 Predictive Toxicology 39 Income Tax Withholding 39 Genetic Variation 39 Disqualification 39 Appraiser Independence 39 Willingness 39 Proposed Revisions 39 Psychological Stress 39 Reasserts 39 Review Mechanism 39 Remain Unclear 39 Dry Powder Inhalers 39 Gene Mutations 39 Reconstitution 39 Impediments 39 Doesn t 39 Atmospheric Carbon Dioxide 39 Low Probability 39 Commitment 39 Higher Doses 39 Progenitor Cells 39 Fampridine SR NDA 39 Substantial Evidence 39 Constrain 39 Clarification 39 Qualitative Analysis 39 Multi Lateral 39 controversial Illegal Migrants 39 Minimum Stockholders Equity 39 Deadline Arrives 39 Lawsuit Dismissal 39 Reforms Needed 39 Sufficient Evidence 39 Graduation Requirements 39 Parental Consent 39 Act Cap. 39 Without Sacrificing 39 CONSOLIDATED SUMMARY OF OPERATIONS 39 Delegate Selection 39 Regulations 39 CFR § #.# [004] 39 Declination 39 Neoadjuvant Chemotherapy 39 Waiver 39 Termination Benefits 39 § #.# [002] 39 REMUNERATION REPORT Audited 39 Harmonized 39 Testamentary 39 Feds Propose 39 Subordination 39 Significantly Improved 39 Order Approving 39 Individuality 39 Possesion 39 Novel Foods 39 Petition 39 Improves Outcomes 39 Non Infringement 39 Langes + 39 FAR #.#-# Affirmative Action 39 Issues Remain 38 Undergo Mental 38 Outcome 38 Remains Elusive 38 Somatic Cell 38 Evaluating 38 HCV Infection 38 Delineates 38 Disconnection 38 Declared Unconstitutional 38 Cytotoxicity 38 Legal Entity 38 #.#-# Prohibition 38 Regress 38 Generic Biologics 38 Considers Easing 38 Reversed 38 Negative Feedback 38 Cohesiveness 38 Substantiation 38 Ex Parte 38 Annulment 38 Dose Response 38 Land Use Permit 38 Set Asides 38 Statistically Significant 38 Consented 38 Appears Unlikely 38 Cont'd 38 Study Pinpoints 38 Bile Acid 38 Deadline Looming 38 Block Copolymer 38 Water Rationing 38 Mismatch 38 Significant Reduction 38 Gov't Urged 38 Prioritization 38 Draws Mixed Reaction 38 Patent Filing 38 Disqualify 38 Abolishment 38 perseverance 38 Non Discriminatory 38 Help Detect 38 Disclosure Requirement 38 Evaporate 38 Unanimous Vote 38 Controversy Surrounds 38 Assert 38 Mixed Feelings About 38 FAR #.# 38 Affirmative Action Ban 38 Refinement 38 Upward Pressure 38 Particle Size 38 ADJUDGED 38 Antibiotic Use 38 Related Transactions 38 Plaintiffs Complaint 38 Rate Adjustment 38 Mad Cow Testing 38 Opinions Differ 38 Decision Delayed 38 Terrorist Acts 38 Gap Persists 38 Input Sought 38 Selection Process 38 Permissible 38 Improves Survival 38 Blames Lack 38 Competency Evaluation 38 Stem Cell Differentiation 38 Or Lack Thereof 38 Androgen 38 Toxicity Testing 38 Mandatory Conversion 38 Prerequisite 38 Provide Valuable 38 Risk Stratification 38 Req 38 Silicone Implants 38 Sexual Assault Cases 38 Poses Serious 38 Halt Enrichment 38 Predictability 38 Competitive Bids 38 Double Lung Transplant 38 Prohibited List 38 Request Denied 38 Election Petitions 38 Overrules 38 Orientated 38 Raises Questions About 38 Helps Predict 38 Suspect Waives 38 Clinical Evaluation 38 Continuous Disclosure 38 Elaboration 38 Powerful Tool 38 Practical Applications 38 Total Knee Arthroplasty 38 Inflammatory Response 38 Move Toward 38 Stiffens 38 Weaken Yen 38 Schwab Declares Regular 38 www.frequencyelectronics.com 38 Royalty Rates 38 Accomplishment 38 WORKING WOUNDED 38 Expedited Review 38 Differentiation 38 Framework Directive 38 Being Studied 38 Rectification 38 Approval Process 38 Notification 38 Physical Function 38 Jury Instructions 38 Claimant argues 38 Dems Urge 38 Enemy Combatant Case 38 Testosterone Patch 38 Mobilises 38 Judicial Tenure 38 Uphold 38 Permitted Uses 38 Avoiding Pitfalls 38 Reverse Transcriptase 38 Antibiotic Treatment 38 Truthfulness Compassion 38 Practice Direction 38 CICA Emerging 38 TCA § #-#-# [001] 38 Fuwei Films Announces 38 Grantee 38 Rate Reduction 38 Extrinsic 38 Breast Cancer Metastasis 38 Age Bias 38 Imaging Techniques 38 Sirius XM Merger 38 Recommendation G.# 38 Tumor Cell 38 Occupational Pension Schemes 38 Sustained Release 38 Prohibited Substance 38 Non Toxic 38 Highest Priority 38 Overrides 38 dated #-#-# [001] 38 Exclusionary 38 Moral Character 38 Technological Advances 38 Banned Substances 38 Assessment Scale 38 Attaining 38 Grandfathered Plans 38 Novel Method 38 Rate Increases 38 Antisocial Behavior 38 Guidance Document 38 NASDAQ Deficiency Notice 38 Termination Payment 38 Pros Cons 38 Categorisation 38 Work SOW 38 Thoroughness 38 Conforms 38 Verifies 38 Impede 38 Proposed Rule Making NPRM 38 Presumptive 38 Not Disclosed 38 Acne Drug 38 Finds Flaws 38 Deepwater Drilling Moratorium 38 Nuclear Intentions 38 Invalidate 38 Smallpox Vaccine 38 Has Passed 38 C.1 38 Prognostic Significance 38 OP# [001] 38 Testing 38 Help Predict 38 Miscalculated 38 Transitory 38 Programmatic 38 Illusory 38 Deregistration 38 Concealed Gun 38 Histological 38 Deactivation 38 Court Throws Out 38 Revised Upward 38 Consideration 38 Suppressive 38 Miraculins Announces 38 Temporary Suspension 38 IND Application 38 Implied Consent 38 Remands 38 Necessity 38 Ban Upheld 38 Litigate 38 Accelrys Announces 38 Targeted Therapy 38 Environmental Impacts 38 Skeletal Muscle 38 Non Discrimination 38 NYSE Arca Listing 38 Reproducibility 38 Sweeping Changes 38 Concentration 38 Inching Toward 38 Waiting Periods 38 Considers Tougher 38 Commissioners Approve 38 Validates 38 Dividend Payment 38 Questions Linger 38 Cyclic 38 Must Rethink 38 Genetically Engineered Animals 38 Preliminary Examination 38 Rearrangements 38 Adjuvant Treatment 38 Novel Compound 38 Mine Subsidence 38 Breast Cancer Cells 38 Cycle Detection 38 Honor Courage 38 Edging Toward 38 Lowest Ever 38 Physical Abuse 38 Immunomedics Announces 38 Detriment 38 Downward Pressure 38 Indecency Fine 38 Radiation Exposure 38 ErP 38 Steep Rise 38 Welfare Recipients 38 Gene Variant 38 Recuse 38 Counteroffer 38 NDA Submission 38 Predicate 38 Tax Exempt Status 38 Non Conformity 38 GeoMet Announces 38 Truthfulness 38 Statutory Basis 38 Voluntary Evacuation 38 Remain Relevant 38 Data Indicate 38 Appellate Panel 38 Enumerated 38 Preliminary Findings 38 Hematopoietic 38 Wastewater Discharge 38 Adversely Affects 38 Breast Tissue 38 Transgenic Plants 38 Unanimously Approves 38 Interferes 38 Invalidated 38 Trickles Down 38 Usefulness 38 Candidature 38 Reinstatement 38 Device Helps 38 Indemnities 38 Retention 38 Moves Towards 38 Complaint Handling 38 Dementia Risk 38 Sewer Rate Hike 38 Graduated License 38 Prompts Changes 38 doc. 38 SEC Regulation SX 38 Favorable Ruling 38 Takeover Bids 38 Wants Tighter 38 § #-#.# [001] 38 Binding Arbitration 38 Sanction